Literature DB >> 3578368

Paucity of minimal-change lesion in children with early frequently relapsing steroid-responsive nephrotic syndrome.

H Trachtman, F Carroll, K Phadke, M Khawar, A Nicastri, C K Chen, A Tejani.   

Abstract

It is widely believed that the most common morphological lesion in children with the idiopathic nephrotic syndrome who manifest a frequently relapsing steroid-responsive course is the minimal-change lesion. However, there are no prospective renal biopsy studies in such patients to substantiate this assertion. We performed a renal biopsy in all children with early frequently relapsing steroid-responsive nephrotic syndrome during the years 1980-1984. In 16 affected children, only 4 (25%) had minimal-change lesion, 7 had IgM nephropathy, 3 had diffuse mesangial hypercellularity, and 2 had focal segmental glomerulosclerosis. Fourteen of these patients have required immunosuppressive therapy with cyclophosphamide. Long-term follow-up revealed that 10 patients have remained protein free, 4 have persistent proteinuria despite cyclophosphamide therapy, 1 had progressed to end-stage renal disease, and 1 is lost to follow-up. On the basis of these findings, we recommend that all children with nephrotic syndrome and an early frequently relapsing steroid-responsive course undergo a prompt renal biopsy. Such patients constitute a high-risk group with a spectrum of renal histopathological lesions characterized by an unpredictable response to therapy and an unfavorable prognosis.

Entities:  

Mesh:

Year:  1987        PMID: 3578368     DOI: 10.1159/000167422

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  1 in total

1.  Efficacy of mycophenolate treatment in adults with steroid-dependent/frequently relapsing idiopathic nephrotic syndrome.

Authors:  Diego Sandoval; Rafael Poveda; Juliana Draibe; Laureà Pérez-Oller; Montserrat Díaz; José Ballarín; Anna Saurina; Helena Marco; Josep Bonet; Xoana Barros; Xavier Fulladosa; Joan Torras; Josep M Cruzado
Journal:  Clin Kidney J       Date:  2017-04-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.